Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Memorial Sloan Kettering Westchester (All Protocol Activities)

Harrison, New York 10604, United StatesNot linked to an institution yet

61running trials
9closed trials

The trials here

What the 70 trials at this site are about, from their registry records.

Conditions: Lung cancer16 trials
Endometrial cancer6 trials
Multiple myeloma6 trials
Kidney cancer5 trials
Pancreatic cancer5 trials
Bladder cancer4 trials
Chronic lymphocytic leukaemia4 trials
Melanoma4 trials
Metastatic breast cancer4 trials
Colorectal cancer3 trials
Ovarian cancer3 trials
Sarcoma3 trials
and 17 more
Phase: Phase 234 trials
Phase 19 trials
Phase 1/24 trials
Phase 32 trials
Early phase 11 trial
Phase 41 trial
Status: Recruiting44 trials
Active, not recruiting17 trials
Completed7 trials
Terminated2 trials
Lead sponsor: Memorial Sloan Kettering Cancer Center70 trials

Running trials

Recruiting
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer
NCT07895498· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Allison Gordon, MD
Recruiting
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
NCT07890415· Phase 3· Memorial Sloan Kettering Cancer Center· Source
Contact: Veronica Rotemberg, MD
Recruiting
A Study of Treatment Delivery Preference In People With Kidney Cancer
NCT07872553· Phase 4· Memorial Sloan Kettering Cancer Center· Source
Contact: Sahil Doshi, MD
Recruiting
A Study of Lung Cancer Risk
NCT07701733· Memorial Sloan Kettering Cancer Center· Source
Contact: Alexis Chidi, MD, PhD
Recruiting
A Study of CRD3874-SI in People With Leukemia
NCT07661095· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Leora Boussi, MD
Recruiting
A Study of a Side Effects and Resource Navigation Program for People With Cancer
NCT07646847· Memorial Sloan Kettering Cancer Center· Source
Contact: Francesca Gany, MD, MS
Recruiting
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07619339· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Paul Paik, MD
Recruiting
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
NCT07594522· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source
Contact: Narek Shaverdian, MD
Recruiting
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
NCT07535463· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source
Contact: Luke Pike, MD, PhD
Recruiting
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
NCT07535437· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source
Contact: Helena Yu, MD
Recruiting
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
NCT07532902· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Michael Offin, MD
Recruiting
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
NCT07454382· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Alexander Lesokhin, MD
Recruiting
A Study of Isoquercetin in People With Ovarian Cancer
NCT07303894· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Jeffrey Zwicker, MD
Recruiting
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
NCT07270666· Memorial Sloan Kettering Cancer Center· Source
Contact: Ying Lui, MD
Recruiting
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
NCT07227636· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Neil Segal, MD, PhD
Recruiting
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
NCT07218601· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Gaetano Rocco, MD
Recruiting
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
NCT07063212· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Winston Wong, MD
Recruiting
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
NCT07052916· Memorial Sloan Kettering Cancer Center· Source
Contact: Kevin Liou, MD
Recruiting
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
NCT07029217· Phase 3· Memorial Sloan Kettering Cancer Center· Source
Contact: Brandon Imber, MD
Recruiting
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Zainab Shahid, MBBS
Recruiting
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
NCT06954337· Memorial Sloan Kettering Cancer Center· Source
Contact: Erin Bange, MD, MSCE
Recruiting
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
NCT06934889· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Thomas Kaley, MD
Recruiting
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
NCT06925724· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Maria Rubenstein, MD
Recruiting
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
NCT06765317· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Pallawi Torka, MD
Recruiting
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
NCT06741085· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Luke Pike, MD
Recruiting
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334· Memorial Sloan Kettering Cancer Center· Source
Contact: Alexis Chidi, MD, PhD
Recruiting
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
NCT06678269· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Lior Braunstein, MD
Recruiting
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
NCT06698003· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Steven Horwitz, MD
Recruiting
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
NCT06594991· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: James Smithy, MD
Recruiting
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
NCT06377566· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Robert Stuver, MD
Active, not recruiting
A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers
NCT06243757· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
NCT06132945· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Recruiting
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
NCT06129903· Memorial Sloan Kettering Cancer Center· Source
Contact: Meredith Bartelstein, MD
Recruiting
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
NCT06099769· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Tiffany Traina, MD
Recruiting
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894· Memorial Sloan Kettering Cancer Center· Source
Contact: Urvi A Shah, MD, MS
Recruiting
Using Urine Samples to Identify Lung Cancer
NCT06033248· Memorial Sloan Kettering Cancer Center· Source
Contact: Gaetano Rocco, MD
Active, not recruiting
A Study Comparing Mindfulness Apps to Decrease Anxiety in People With Lung Cancer
NCT06008574· Memorial Sloan Kettering Cancer Center· Source
Recruiting
A Registry for People With T-cell Lymphoma
NCT05978141· Memorial Sloan Kettering Cancer Center· Source
Contact: Steven Horwitz, MD
Recruiting
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
NCT05837767· Memorial Sloan Kettering Cancer Center· Source
Contact: Atif Khan, MD
Active, not recruiting
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
NCT05912244· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer
NCT05793593· Memorial Sloan Kettering Cancer Center· Source
Recruiting
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
NCT05691010· Early phase 1· Memorial Sloan Kettering Cancer Center· Source
Contact: Kaled Alektiar, MD
Recruiting
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
NCT05657873· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Paul Romesser, MD
Recruiting
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
NCT05640843· Memorial Sloan Kettering Cancer Center· Source
Contact: Urvi A Shah, MD, MS
Recruiting
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
NCT04991025· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Paul Paik, MD
Recruiting
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
NCT05570253· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Sherry Shen, MD
Active, not recruiting
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
NCT05169970· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Active, not recruiting
A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
NCT04722172· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Recruiting
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
NCT04774419· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Contact: Ying Lui, MD
Active, not recruiting
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
NCT04757363· Phase 2· Memorial Sloan Kettering Cancer Center· Source

Showing 50 of 61.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Lung cancer13 recruiting
Endometrial cancer5 recruiting
Multiple myeloma5 recruiting
Bladder cancer3 recruiting
Kidney cancer3 recruiting
Melanoma3 recruiting
Metastatic breast cancer3 recruiting
Pancreatic cancer3 recruiting
Acute lymphoblastic leukaemia2 recruiting
Sarcoma2 recruiting
Acute myeloid leukaemia1 recruiting
Cervical cancer1 recruiting
Childhood cancers1 recruiting
Chronic lymphocytic leukaemia1 recruiting
Colorectal cancer1 recruiting
Diffuse large B-cell lymphoma1 recruiting
Follicular lymphoma1 recruiting
Glioblastoma1 recruiting
Head and neck cancer1 recruiting
Hodgkin lymphoma1 recruiting
Mesothelioma1 recruiting
Ovarian cancer1 recruiting
Prostate cancer1 recruiting
Triple-negative breast cancer1 recruiting

Closed trials

Terminated
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
NCT06333678· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Terminated
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
NCT05788289· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Completed
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
NCT05190770· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Completed
A Study of E7820 in People With Bone Marrow (Myeloid) Cancers
NCT05024994· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Completed
Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
NCT04457284· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Completed
Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT04384146· Phase 1· Memorial Sloan Kettering Cancer Center· Source
Completed
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma
NCT04068831· Phase 2· Memorial Sloan Kettering Cancer Center· Source
Completed
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
NCT03956095· Memorial Sloan Kettering Cancer Center· Source
Completed
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
NCT03767257· Phase 2· Memorial Sloan Kettering Cancer Center· Source

Site data: ClinicalTrials.govUpdated 13 Nov 2026

Report an error